Haemate P 500 IU / 1200 IU I.V. is a high-quality, human plasma-derived concentrate containing Von Willebrand Factor (VWF) and Factor VIII (FVIII), manufactured by CSL Behring, a global leader in plasma protein therapies. It is specifically designed for the prevention and treatment of bleeding episodes in patients suffering from Von Willebrand Disease (VWD) and Hemophilia A.
This dual-component formulation is particularly valuable for individuals with Von Willebrand Disease who require both Factor VIII and Von Willebrand Factor replacement therapy, ensuring rapid bleeding control and effective hemostasis during surgical procedures, trauma, or spontaneous bleeding episodes.
Key Benefits of Haemate P 500 IU / 1200 IU:
- Dual Action: Combines Von Willebrand Factor (VWF) and Factor VIII (FVIII) for comprehensive management of bleeding disorders.
- Immediate Bleeding Control: Rapidly restores VWF and FVIII levels, ensuring effective clot formation and reducing bleeding time.
- Surgical and Emergency Use: Proven efficacy in both preventive pre-surgical administration and emergency bleeding situations.
- Trusted Plasma-Derived Formula: Manufactured from screened human plasma with state-of-the-art viral inactivation processes, ensuring product safety.
- Proven Clinical Efficacy: Extensively studied and widely recommended by hematologists for the treatment of Von Willebrand Disease and Hemophilia A.
Composition:
- 500 IU of Factor VIII (FVIII) per vial.
- 1200 IU of Von Willebrand Factor (VWF) per vial.
Indications:
- Von Willebrand Disease (VWD): For patients when desmopressin (DDAVP) is ineffective or contraindicated.
- Hemophilia A: For the treatment and prevention of bleeding in patients with Factor VIII deficiency.
- Surgical and Dental Procedures: To prevent bleeding complications during invasive interventions.
Dosage & Administration:
- Intravenous Infusion (I.V.): Administered by a healthcare professional.
- Dose Adjustment: Based on the severity of the bleeding episode, body weight, and patient response.
- Pre-Surgical Prophylaxis: Tailored according to the procedure and individual patient requirements.
Safety Information:
- Risk of Thrombosis: Use with caution in patients with thrombotic risk factors.
- Hypersensitivity: Discontinue immediately if allergic reactions occur.
- Infection Risk: Despite advanced purification, the theoretical risk of virus transmission exists, though minimized by modern plasma screening and viral inactivation techniques.
Common Side Effects:
- Mild headache
- Nausea
- Flushing
- Injection site reactions
Storage Instructions:
- Store in a refrigerator between 2°C to 8°C.
- Do not freeze.
- Protect from light and keep in the original packaging until use.
Why Choose Haemate P 500 IU / 1200 IU?
Haemate P is a gold standard treatment for Von Willebrand Disease and Hemophilia A, trusted globally by hematology experts. Its precise combination of VWF and FVIII ensures patients receive comprehensive coverage, reducing the risk of prolonged bleeding episodes and offering peace of mind during critical medical procedures.
Manufacturer & Origin:
- Brand: Haemate P
- Manufacturer: CSL Behring
- Country of Origin: Germany
Buy Haemate P 500 IU / 1200 IU I.V. Online:
We supply genuine Haemate P 500 IU / 1200 IU infusion products sourced directly from CSL Behring distributors. Our streamlined ordering process ensures fast, secure delivery worldwide. Safeguard your health with trusted coagulation factor therapy – place your order today.
Değerlendirmeler
Henüz değerlendirme yapılmadı.